Essais liés10clinical trials
VilleAlbanylocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05617014

Ouvrir le site du centre

Essais cliniques associés

10
MoléculeIndication / populationPhaseNCTTitreStatut
lorundrostat Hypertension Phase 3 NCT05968430 Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension ACTIVE_NOT_RECRUITING
Eptinezumab Migraine Phase 4 NCT06701526 A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications COMPLETED
Low Dose Benfotiamine Alzheimer Phase 2 NCT06223360 A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) ACTIVE_NOT_RECRUITING
Vivistim System SEP À vérifier NCT05301140 Vivistim Registry for Paired VNS Therapy (GRASP) RECRUITING
Donanemab Alzheimer Phase 3 NCT04437511 A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) ACTIVE_NOT_RECRUITING
AIDP — Automated Imaging Differentiation of Parkinsonism Parkinson À vérifier NCT05913687 AIDP — Automated Imaging Differentiation of Parkinsonism ACTIVE_NOT_RECRUITING
Neuraceq Alzheimer À vérifier NCT05617014 ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4 ENROLLING_BY_INVITATION
Erenumab Migraine Phase 4 NCT04825678 A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine COMPLETED
Deep Brain Stimulation (DBS) Parkinson À vérifier NCT02071134 Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry RECRUITING
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity Alzheimer À vérifier NCT01078636 ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity COMPLETED